English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer. Journal article
Wang Jian, Li RunZe, Wang WenJun, Pan HuDan, Xie Chun, Yau LeeFong, Wang XingXia, Long WeiLi, Chen RuiHong, Liang TuLiang, Ma LinRui, Li JiaXin, Huang JuMin, Wu QiBiao, Liu Liang, He JianXing, Leung Elaine Lai Han. CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer.[J]. Pharmacological Research, 2023.
Authors:  Wang Jian;  Li RunZe;  Wang WenJun;  Pan HuDan;  Xie Chun; et al.
Adobe PDF | Favorite |   IF:9.1/9.0 | Submit date：2023/10/23
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer Journal article
Wang Jian, Li RunZe, Wang WenJun, Pan HuDan, Xie Chun, Yau LeeFong, Wang XingXia, Long WeiLi, Chen RuiHong, Liang TuLiang, Ma LinRui, Li JiaXin, Huang JuMin, Wu QiBiao, Liu Liang, He JianXing, Leung Elaine Lai Han. CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer[J]. Pharmacological Research, 2023, 194, 106850.
Authors:  Wang Jian;  Li RunZe;  Wang WenJun;  Pan HuDan;  Xie Chun; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Cd8++++ Tim-3++++ t Cell  Cers4  Icis  Nsclc  Rhob  Sphingolipid Metabolism  
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance Journal article
Li RunZe, Wang XuanRun, Wang Jian, Xie Chun, Wang XingXia, Pan HuDan, Meng WeiYu, Liang TuLiang, Li JiaXin, Yan PeiYu, Wu QiBiao, Liu Liang, Yao XiaoJun, Leung Elaine Lai Han. The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance[J]. Frontiers in Oncology, 2022.
Authors:  Li RunZe;  Wang XuanRun;  Wang Jian;  Xie Chun;  Wang XingXia; et al.
Favorite |   IF:3.5/4.0 | Submit date：2023/06/15